π
|
Human diversity in killer cell inhibitory receptor genes.
9 auth.
M. Uhrberg,
N. Valiante,
B. Shum,
H. Shilling,
K. Lienert-Weidenbach,
B. Corliss,
...
D. Tyan,
L. Lanier,
P. Parham
|
10 |
1997 |
10 π
|
π
|
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
27 auth.
B. Tait,
C. SΓΌsal,
H. Gebel,
P. Nickerson,
A. Zachary,
F. Claas,
E. Reed,
Robert A. Bray,
P. Campbell,
J. Chapman,
P. Coates,
R. Colvin,
E. Cozzi,
I. Doxiadis,
S. Fuggle,
...
J. Gill,
D. Glotz,
N. Lachmann,
T. Mohanakumar,
N. Suciu-Foca,
S. SumitranβHolgersson,
K. Tanabe,
C. Taylor,
D. Tyan,
A. Webster,
A. Zeevi,
G. Opelz
|
9 |
2013 |
9 π
|
π
|
National Conference to Assess AntibodyβMediated Rejection in Solid Organ Transplantation
15 auth.
S. Takemoto,
A. Zeevi,
S. Feng,
R. Colvin,
S. Jordan,
J. Kobashigawa,
J. Kupiec-Weglinski,
A. Matas,
R. Montgomery,
P. Nickerson,
...
J. Platt,
H. Rabb,
R. Thistlethwaite,
D. Tyan,
F. Delmonico
|
8 |
2004 |
8 π
|
π
|
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
16 auth.
S. Jordan,
D. Tyan,
D. Stablein,
Matthew J. McIntosh,
S. Rose,
A. Vo,
M. Toyoda,
C. Davis,
R. Shapiro,
D. Adey,
...
D. Milliner,
R. Graff,
R. Steiner,
G. Ciancio,
Shobah Sahney,
J. Light
|
8 |
2004 |
8 π
|
π
|
Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.
18 auth.
D. Levine,
A. Glanville,
C. Aboyoun,
J. Belperio,
C. Benden,
G. Berry,
R. Hachem,
D. Hayes,
D. Neil,
N. Reinsmoen,
...
L. Snyder,
S. Sweet,
D. Tyan,
G. Verleden,
G. Westall,
R. Yusen,
M. Zamora,
A. Zeevi
|
8 |
2016 |
8 π
|
π
|
Allelic Polymorphism Synergizes with Variable Gene Content to Individualize Human KIR Genotype1
7 auth.
H. Shilling,
L. Guethlein,
Nathalie W. Cheng,
C. Gardiner,
Roberto RodrΓguez,
D. Tyan,
...
P. Parham
|
8 |
2002 |
8 π
|
π’
|
Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action.
10 auth.
S. Jordan,
A. Quartel,
L. Czer,
D. Admon,
Ge Chen,
M. Fishbein,
...
Jeremy Schwieger,
R. Steiner,
C. Davis,
D. Tyan
|
8 |
1998 |
8 π’
|
π
|
Distinct associations of HLA class II genes with inflammatory bowel disease.
11 auth.
H. Toyoda,
Sue-Jane Wang,
Hui-ying Yang,
Andreea Redford,
D. Magalong,
D. Tyan,
...
C. McElree,
S. Pressman,
F. Shanahan,
S. Targan,
J. Rotter
|
8 |
1993 |
8 π
|
π¦
|
Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.
D. Tyan,
Victoria A. Li,
L. Czer,
A. Trento,
S. C. Jordan
|
7 |
1994 |
7 π¦
|
π
|
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans
32 auth.
P. Norman,
Laurent Abi-Rached,
K. Gendzekhadze,
D. Korbel,
Michael Gleimer,
D. Rowley,
D. Bruno,
Christine V F Carrington,
D. Chandanayingyong,
Yih-Hsin Chang,
C. Crespi,
G. Saruhan-Direskeneli,
Patricia A Fraser,
K. Hameed,
Giorgi Kamkamidze,
...
K. Koram,
Z. Layrisse,
N. Matamoros,
J. MilΓ ,
Myoung Hee Park,
Ramasamy Pitchappan,
D. Ramdath,
M. Shiau,
Henry A F Stephens,
S. Struik,
D. Verity,
Robert W Vaughan,
D. Tyan,
Ronald W Davis,
Eleanor M. Riley,
M. Ronaghi,
P. Parham
|
7 |
2007 |
7 π
|
π’
|
Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.
Ge Chen,
F. Sequeira,
D. Tyan
|
7 |
2011 |
7 π’
|
π
|
Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells.
9 auth.
I. Avital,
D. Inderbitzin,
T. Aoki,
D. Tyan,
A. Cohen,
C. Ferraresso,
...
J. Rozga,
W. Arnaout,
A. Demetriou
|
7 |
2001 |
7 π
|